L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
YJdZkXarkYxfkfT2
